Mineralys Therapeutics, Inc. MLYS Unrecognized Tax Benefits - Income Tax Penalties and Interest Accrued
Unrecognized Tax Benefits - Income Tax Penalties and Interest Accrued at other companies
Other financials
Where this comes from
Reported directly by Mineralys Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncomeTaxExaminationPenaltiesAndInterestAccrued.
The official record: Mineralys Therapeutics, Inc.’s 10-K, filed March 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Mineralys Therapeutics, Inc.'s unrecognized tax benefits - income tax penalties and interest accrued.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Mineralys Therapeutics, Inc.'s unrecognized tax benefits - income tax penalties and interest accrued?
- Mineralys Therapeutics, Inc. (MLYS) reported unrecognized tax benefits - income tax penalties and interest accrued of $0 in Q4 2025.
- What does unrecognized tax benefits - income tax penalties and interest accrued mean?
- This metric tracks the accrued interest and penalties associated with the company's unrecognized tax benefits. It represents the additional cost the company would incur if its uncertain tax positions were disallowed by tax authorities. It serves as a proxy for the financial risk associated with the company's tax strategy.